Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

5,395 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pharmacokinetics and safety of IBI301 versus rituximab in patients with CD20+ B-cell lymphoma: a multicenter, randomized, double-blind, parallel-controlled study.
Jiang B, Ke X, Zhang Q, Xu W, Su H, Huang J, Zhang M, Wang H, Jin C, Zhu J, Liu L, Cai Z, Zhao X, Zhou J, Zhang X, Liu J, Zhou H, Yu J, Sun X, Qi J, Qiu L. Jiang B, et al. Sci Rep. 2020 Jul 15;10(1):11676. doi: 10.1038/s41598-020-68360-0. Sci Rep. 2020. PMID: 32669656
[Intelligent monitoring system assisted pelvic fracture closed reduction for treating one case with complex pelvic fracture].
Chen H, Jiang B, Zhang Q, Chang Z, Yang Z, Zhang J, Liu H, Tang P. Chen H, et al. Among authors: jiang b. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2020 Jul 15;34(7):874-877. doi: 10.7507/1002-1892.202001035. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2020. PMID: 32666731 Chinese.
Health impacts of environmental contamination of micro- and nanoplastics: a review.
Jiang B, Kauffman AE, Li L, McFee W, Cai B, Weinstein J, Lead JR, Chatterjee S, Scott GI, Xiao S. Jiang B, et al. Environ Health Prev Med. 2020 Jul 14;25(1):29. doi: 10.1186/s12199-020-00870-9. Environ Health Prev Med. 2020. PMID: 32664857 Review.
Pamiparib is a potent and selective PARP inhibitor with unique potential for the treatment of brain tumor.
Xiong Y, Guo Y, Liu Y, Wang H, Gong W, Liu Y, Wang X, Gao Y, Yu F, Su D, Wang F, Zhu Y, Zhao Y, Wu Y, Qin Z, Sun X, Ren B, Jiang B, Jin W, Shen Z, Tang Z, Song X, Wang L, Liu X, Zhou C, Jiang B. Xiong Y, et al. Among authors: jiang b, jiang b. Neoplasia. 2020 Jul 8;22(9):431-440. doi: 10.1016/j.neo.2020.06.009. Online ahead of print. Neoplasia. 2020. PMID: 32652442 Free PMC article.
5,395 results
Jump to page